News | May 07, 2007

Novel Intraoperative Probe Proves Effective

May 8, 2007 - According to two separate studies recently presented at the American Society of Breast Surgeons (ASBS) Annual Meeting, an intraoperative breast cancer probe shows significant potential for reducing positive surgical margins in lumpectomy patients, including those with hard-to-detect, pre-invasive, ductal carcinoma in situ (DCIS).

A cancer patient with positive margins typically requires a second surgery, with accompanying trauma and expense, to re-shave tumor sites for adequate tissue removal. The Dune Medical (Caesarea, Israel) probe uses radiofrequency spectroscopy to characterize breast tissue in real-time during surgery to determine margin malignancy status and holds promise to reduce re-excision procedures.
Selected for oral presentation at the 2007 ASBS conference, the first study found that the device fully detected 86 percent of positive margin patients during surgery, potentially converting them to negative status during this initial procedure. In the study, intact lumpectomy specimens were sampled immediately following excision by applying the Dune probe to multiple measurement sites on each margin examined. The probe readings were compared with post-operative pathology results on the same precisely identified margin areas. Conducted at two medical centers, the trial analyzed 314 breast tumor margins with approximately 3600 measurement points.
The second study, presented as an ASBS poster, found that the Dune device was able to identify 20 out of 21 DCIS sites post-operatively on freshly excised breast cancer tissue as verified by pathology reports. This study involved 46 lumpectomy specimens and 282 measurement sites, which were carefully selected to exclude tumor-concentrated sites. The Dune device also identified pathologies for a full range of additional breast tumor types with complete or high degree accuracy.
According to lead study author Dr. Tami Karni of the Sackler School of Medicine, Tel Aviv University, Israel and the Breast Care Institute, Assaf Harofe Medical Center, Israel, the primary objective of breast conservation surgery today is to achieve complete excision of tumors surrounded by a rim of pathology-free tissue. However, a large percentage of women must undergo re-excision surgeries because post-operative pathology reports show margin disease.

Related Content

An example of Philips' TrueVue technology, which offers photo-realistic rendering and the ability to change the location of the lighting source on 3-D ultrasound images. In this example of two Amplazer transcatheter septal occluder devices in the heart, the operator demonstrating the product was able to push the lighting source behind the devices into the other chamber of the heart. This illuminated a hole that was still present that the occluders did not seal.

An example of Philips' TrueVue technology, which offers photo-realistic rendering and the ability to change the location of the lighting source on 3-D ultrasound images. In this example of two Amplazer transcatheter septal occluder devices in the heart, the operator demonstrating the product was able to push the lighting source behind the devices into the other chamber of the heart. This illuminated a hole that was still present that the occluders did not seal. 

Feature | Ultrasound Imaging | February 07, 2019 | Dave Fornell, Editor
Here is a list of six key trends in ul...
ASE Releases Guidelines for Transesophageal Echo in Congenital Heart Disease
News | Ultrasound Transesophageal echo (TEE) | February 05, 2019
February 5, 2019 – The American Society of Echocardiography (ASE) released a new document that provides a comprehensi
Siemens Healthineers Introduces Portable Cardiovascular-Dedicated Ultrasound at ACC.18
News | Cardiovascular Ultrasound | March 13, 2018
At the American College of Cardiology’s (ACC) 67th Annual Scientific Session and Expo, March 10-12 in Orlando, Fla.,...
Csound, GE ultrasound, cSound, Mitral valve, cardiac ultrasound, cardiac echo, echocardiography, echo advances, ASE.16, ASE 2016, advances in cardiovascular ultrasound

An example of improved cardiac ultrasound image processing using the GE cSound technology, which can create CT-like quality 3-D renderings of the anatomy.

Feature | Cardiovascular Ultrasound | July 11, 2016 | Dave Fornell
There were several overall key trends evident at the 2016 meeting of the American Society of Echocardiography in June
Videos | Cardiovascular Ultrasound | June 28, 2016
Interview with MD Buyline clinical analysts Jon Brubaker and Sabrina Newell at the American Society of Echocardiograp
Videos | Cardiovascular Ultrasound | June 28, 2016
Interview with Rebecca Hahn, M.D., FASE, Columbia University Medical Center, New York, at the American Society of Ech
News | Ultrasound Transesophageal echo (TEE) | April 21, 2016
CS Medical announced the release of their newest product designed to aid in the circle of care for transesophageal echo...
Videos | Cardiovascular Ultrasound | June 26, 2015
DAIC Editor Dave Fornell shares his choices for the most innovative new echocardiography technologies and trends at t
Videos | Cardiovascular Ultrasound | June 17, 2015
Role of Interventional Echcardiography in Transcatheter Structural Heart Procedures — Rebecca Hahn, M.D., Columbia Un